欧陆通 reported revenue of ¥2.51B for the period ended 2026-06-30, +18.3% year on year. Net income was ¥0.01B, a 0.3% net margin on a 17.9% gross margin. The largest revenue line is 数据中心电源 at 45% of the total. Free cash flow for the period was ¥-0.22B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥2.51B | +18.3% |
| Gross profit | ¥0.45B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.01B | -93.8% |
| Gross margin | 17.9% | Net margin 0.3% |
| Revenue Q/Q | +40.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 数据中心电源 | ¥1.14B | 45.3% |
| 消费电子电源(原电源适配器) | ¥0.92B | 36.7% |
| 锂电设备电源及其他(原其他电源) | ¥0.43B | 17.1% |
| 其他(补充) | ¥0.02B | 0.9% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥2.06B | 82.1% |
| R&D | ¥0.18B | 7.0% |
| SG&A | ¥0.14B | 5.7% |
| Tax & other | ¥0.03B | 1.3% |
| Item | Amount |
|---|---|
| Total assets | ¥6.37B |
| Total liabilities | ¥3.74B |
| Shareholders' equity | ¥2.63B |
| Equity / assets | 41.3% |
| Operating cash flow | ¥-0.12B |
| Capital expenditure | ¥0.10B |
| Free cash flow | ¥-0.22B |
| Cash conversion (OCF / net income) | -1152% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
回盛生物 ・ 天阳科技 ・ 海晨股份 ・ 捷强装备 ・ 蒙泰高新 ・ 金春股份 ・ 维康药业 ・ 大叶股份 ・ 迦南智能 ・ 盛德鑫泰 ・ 万胜智能 ・ 龙利得
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies